Arm and Intel surge 4.9% and 10.8% as AI chip race intensifies

Arm's licensing model and Intel's foundry bet represent two competing visions for the $600 billion-plus semiconductor market.

Arm Holdings (ARM) and Intel (INTC) both surged on the same trading day, rising 4.9% and 10.8% respectively, as investors weighed two divergent strategies for capturing AI chip demand — Arm's licensing and efficiency model versus Intel's foundry and data center turnaround.

"Arm's architecture is becoming the default for energy-efficient AI inference, while Intel's foundry services could reshape chip manufacturing if execution holds," the comparative analysis noted, highlighting the market debate between the two approaches.

Intel reported fiscal 2025 revenue of nearly $52.9 billion, though it posted a net loss of $60 million as it funds its foundry transition. The company's debt-to-equity ratio stood at 0.4x with a current ratio of 2.0x, reflecting a manageable balance sheet during the restructuring. Arm, by contrast, generates revenue through licensing its chip architecture to partners including Apple, Nvidia, and Qualcomm — a capital-light model that has gained traction as AI workloads shift toward power-constrained data centers and edge devices.

The divergence matters because the two companies represent competing bets on how the semiconductor industry will evolve. Intel is spending billions to catch Taiwan Semiconductor Manufacturing Co. (TSMC) in advanced process nodes, aiming to become a major foundry for external chip designers. Arm is expanding beyond mobile into data center CPUs and AI accelerators, where its energy-efficient designs appeal to cloud providers seeking to cut power costs.

Intel's Foundry Pivot Carries Execution Risk

Intel's strategy hinges on its Intel Foundry Services, which aims to manufacture chips for third-party customers using advanced nodes such as 18A (the equivalent of roughly 1.8nm). The company's net loss of $60 million on $52.9 billion in revenue — a net margin of negative 0.1% — reflects the heavy investment required. Intel's forward price-to-earnings ratio of 114.2x signals that investors are pricing in a successful turnaround rather than current earnings power.

The foundry business faces an uphill battle against TSMC, which commands more than 90% of the advanced chip manufacturing market at nodes below 7nm. Intel must also compete with Samsung Foundry for external customers. Any delays in Intel's 18A node timeline could push potential clients to commit capacity with TSMC instead, locking Intel out of the foundry market for years.

Arm's Licensing Model Gains AI Tailwinds

Arm's architecture powers more than 99% of mobile processors and is increasingly used in data centers, where Amazon's Graviton and Nvidia's Grace CPU both rely on Arm designs. The company's licensing model generates high-margin revenue without the capital intensity of owning fabs. As AI inference workloads — the process of running trained models — expand across cloud and edge devices, Arm's energy-efficient designs offer a power cost advantage over x86-based alternatives from Intel and Advanced Micro Devices (AMD).

Arm's total addressable market has expanded beyond mobile into cloud computing, automotive, and the Internet of Things. The company's v9 architecture, which includes built-in security and AI acceleration features, commands higher royalty rates than previous generations, providing a revenue growth lever independent of unit volume increases.

For investors, the choice between Arm and Intel comes down to risk tolerance. Arm offers exposure to AI growth through a capital-light IP model, while Intel represents a higher-risk bet on manufacturing revival. Intel shares trade at 114.2x forward earnings and 12.5x sales, compared with the semiconductor sector's 28.7x forward P/E benchmark, according to Financial Modeling Prep data. If Intel's foundry strategy succeeds, the current valuation could prove cheap; if it falters, Arm's licensing model may deliver more consistent returns as AI adoption accelerates.

This article is for informational purposes only and does not constitute investment advice.